Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Sun-Young Kong, Kwang-Soo Kim, Jiewan Kim, Min Kyeong Kim, Ki Hong Lee, Je-Yong Lee, Nuri Oh, Ji-In Park, Ji-Hoon Park, Sun-Hee Heo, Sung Han Shim, Dong Ryul Lee, Keun Pil Kim, Kyung-Soon Park
Published Aug 19, 2016 · Vol. 7, No. 40 · pp. 65137-65146
Shiri Yacobovich, Lena Tuchinsky, Michael Kirby, Tetiana Kardash, Oryan Agranyoni, Elimelech Nesher, Boris Redko, Gary Gellerman, Dror Tobi, Katerina Gurova, Igor Koman, Osnat Ashur Fabian, Albert Pinhasov
Published Aug 18, 2016 · Vol. 7, No. 39 · pp. 63549-63560